NCT06960577 2026-02-23Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2)AstraZenecaPhase 3 Recruiting150 enrolled
NCT00520403 2014-10-13A Study of Avastin (Bevacizumab) in Combination With Standard Therapy in Patients With Metastatic Renal Cell Cancer.Hoffmann-La RochePhase 2 Completed25 enrolled 8 charts